Chinanews, February 24, a comprehensive report. Recently, Hans Kluge, director of the World Health Organization's European Regional Office, predicted that the new crown epidemic may end in early 2022.

In order to prevent and control the epidemic, many countries are stepping up the promotion of new crown vaccination. On the 23rd, drugmakers told the US Congress that they plan to substantially increase the delivery of new crown vaccines in the next few weeks.

On February 16, local time, the mass vaccination station set up at Oakland Stadium, California, was opened to eligible people.

This vaccination station will provide 6000 doses of vaccine every day.

Photo by China News Agency reporter Liu Guanguan

　　According to reports, Kruger, director of the World Health Organization’s European Regional Office, said that the worst has passed, and people know more about the new coronavirus than when it first spread in 2020.

　　Kruger believes that the new crown epidemic may end in early 2022.

This virus will continue to exist among people, but the necessary restrictions will be a thing of the past.

However, he emphasized that this is only a prediction, because no one can say exactly how the situation will develop.

　　At present, in order to prevent and control the epidemic, countries are stepping up to promote new crown vaccination.

According to the US Centers for Disease Control and Prevention (CDC), as of February 23, 82.1 million doses of the new crown vaccine have been delivered across the United States, and approximately 65 million doses have been injected.

　　On the same day, at the hearing on the production and delivery of the new crown vaccine in the US House of Representatives, drugmakers also stated that they plan to substantially increase delivery in the next few weeks.

　　Pfizer and Modena are the only two companies that have been authorized by the U.S. Food and Drug Administration (FDA) for emergency new crown vaccines. Executives of the two companies said that by the end of March, they will be able to deliver more than 130 million additional doses of vaccine.

According to the contract with the U.S. federal government, the two companies will provide 600 million doses of vaccines across the United States, and they said they will be able to deliver them all by the end of July.

On January 26, local time, a pedestrian wearing a mask exiting the station at Pennsylvania Train Station in New York, USA.

Photo by China News Agency reporter Liao Pan

　　John Young, Pfizer’s chief business officer, told the House of Representatives that the company has so far delivered only about 40 million doses of vaccine to the US government.

But John Young said the company is expected to deliver a total of 120 million doses by the end of March and another 80 million doses by the end of May.

　　Johnson & Johnson, which has not received emergency authorization, said it plans to provide enough vaccine doses to more than 20 million Americans by the end of March.

Unlike Pfizer and Modena’s vaccines, Johnson & Johnson only needs one injection, so 20 million doses of vaccine can be vaccinated for 20 million people.

　　Richard Nettles, vice president of medical affairs for Johnson & Johnson's Janssen Infectious Diseases and Vaccine Division, said that if the vaccine is authorized by the FDA, 4 million doses of the vaccine will be available for immediate shipment.

The FDA advisory committee will hold a meeting on the 26th to review the company's application. It is widely expected that the emergency application will be approved soon.

　　At the same time, the Biden government of the United States is also increasing its distribution to various states.

White House spokesperson Shaqi said on February 23 that the total number of vaccines sent to the country every week has increased to 14.5 million doses, an increase of about 1 million doses from before.